PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neuroscience, Imaging and Clinical Science, \'G. d\'Annunzio\' University of Chieti-Pescara, Chieti, Italy.\', \'Department of Neuroscience, Imaging and Clinical Science, \'G. d\'Annunzio\' University of Chieti-Pescara, Chieti, Italy. fedele.dono@unich.it.\', \'Department of Neurology, Headache Center, \'SS Annunziata\' Hospital, Chieti, Italy.\', \'Department of Neurology, Headache Center, \'SS Annunziata\' Hospital, Chieti, Italy. l.bonanni@unich.it.\', \'Department of Medicine and Aging Sciences, \'G. d\'Annunzio\' University of Chieti-Pescara, Chieti, Italy. l.bonanni@unich.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s10072-021-05741-x
?:doi
?:hasPublicationType
?:journal
  • Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
is ?:pmid of
?:pmid
?:pmid
  • 34807361
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all